Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun;46(4):303-322.
doi: 10.1111/nan.12587. Epub 2019 Nov 25.

Review: Danon disease: Review of natural history and recent advances

G Cenacchi  1 , V Papa  1 , V Pegoraro  2 , R Marozzo  2 , M Fanin  3 , C Angelini  4
Affiliations
Review

Review: Danon disease: Review of natural history and recent advances

G Cenacchi et al. Neuropathol Appl Neurobiol. 2020 Jun.

Abstract

Danon disease is a severe multisystem disorder clinically characterized by hypertrophic cardiomyopathy, skeletal myopathy and mental retardation in male patients, and by a milder phenotype (predominantly involving cardiac muscle) in female patients. The disease is inherited as an X-linked dominant trait. The primary deficiency of lysosome-associated membrane protein-2 (LAMP-2) causes disruption of autophagy, leading to an impaired fusion of lysosomes to autophagosomes and biogenesis of lysosomes. We surveyed over 500 Danon disease patients reported in the literature from the first description to the present, in order to summarize the clinical, pathological and molecular data and treatment perspectives. An early molecular diagnosis is of crucial importance for genetic counselling and for therapeutic interventions: in male patients, the prognosis is poor due to rapid progression towards heart failure, and only heart transplantation modifies the disease course.

Keywords: Danon disease; LAMP-2; Wolff-Parkinson-White syndrome; hypertrophic cardiomyopathy; vacuolar myopathy.

PubMed Disclaimer

References

    1. Danon MJ, Oh SJ, DiMauro S, Manaligod JR, Eastwood A, Naidu S et al. Lysosomal glycogen storage disease with normal acid maltase. Neurology 1981; 31: 51-7
    1. Nishino I, Fu J, Tanji K, Yamada T, Shimojo S, Koori T et al. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature 2000; 406: 906-10
    1. Sugie K, Koori T, Yamamoto A, Ogawa M, Hirano M, Inoue K et al. Characterization of Danon disease in a male patient and his affected mother. Neuromuscul Disord 2003; 13: 708-11
    1. Yang Z, McMahon CJ, Smith LR, Bersola J, Adesina AM, Breinholt JP et al. Danon disease as an under-recognized cause of hypertrophic cardiomyopathy in children. Circulation 2005; 112: 1612-7
    1. Fu L, Luo S, Cai S, Hong W, Guo Y, Wu J et al. Identification of LAMP2 mutations in early-onset Danon disease with hypertrophic cardiomyopathy by targeted next-generation sequencing. Am J Cardiol 2016; 118: 888-94

LinkOut - more resources